Glox Therapeutics

About:

Glox Therapeutics creates precision antibiotics through the use of engineered protein bacteriocins.

Website: https://gloxtherapeutics.com/

Top Investors: PACE-AMR, Scottish Enterprise, Boehringer Ingelheim Venture Fund

Description:

Glox Therapeutics is a company that is pioneering the development of precision antibiotic therapies based on naturally occurring bacteriocins.

Total Funding Amount:

5.3M GBP

Headquarters Location:

Glasgow, Glasgow City, United Kingdom

Founded Date:

2023-01-01

Contact Email:

j.clark(AT)gloxtherapeutics.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2024-11-20

IPO Status:

Private

Industries:

© 2025 bioDAO.ai